PX4 Stock Chart & Stats
€188.00
€4.00(2.65%)
At close: 4:00 PM EST
€188.00
€4.00(2.65%)
Day’s Range― - ―
52-Week Range€100.00 - €262.00
Previous CloseN/A
Volume20.00
Average Volume (3M)1.00
Market Cap
€6.27B
Enterprise Value€7.82B
Total Cash (Recent Filing)€303.13M
Total Debt (Recent Filing)€267.67M
Price to Earnings (P/E)38.3
Beta0.22
Next Earnings
Jul 29, 2026EPS Estimate
1.87Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.98
Shares Outstanding26,756,420
10 Day Avg. Volume0
30 Day Avg. Volume1
Financial Highlights & Ratios
PEG Ratio0.40
Price to Book (P/B)2.66
Price to Sales (P/S)0.96
P/FCF Ratio25.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€263.03Price Target Upside39.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)7.04
Revenue Forecast (FY)€4.06B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetSustained low leverage provides durable financial flexibility to fund program ramps, capex and strategic investments without forcing dilutive financing. A stronger capital structure reduces refinancing risk over the next 2–6 months and supports opportunistic M&A or share repurchases if cash generation recovers.
Record Program Wins And Expanding FunnelA growing $4B qualified funnel and record wins indicate durable demand and a multi-quarter pipeline of revenue that supports mid‑teens growth guidance. High-conviction program wins reduce sales cyclicality and increase visibility into future capacity utilization and revenue mix over the medium term.
Strong Capital Efficiency (ROIC)ROIC materially above cost of capital demonstrates disciplined allocation and returns on invested capital. This structural efficiency supports attractive long-term cash generation potential as ramps scale, enabling reinvestment, debt paydown or shareholder returns even if margins fluctuate in the near term.
Bears Say
Weakened Free Cash Flow ConversionDeclining FCF conversion reduces near-term financial flexibility and constrains the firm's ability to fund capex, working capital needs and buybacks without increasing leverage. If conversion does not normalize, planned investments and guidance-linked cash targets may be harder to achieve over the next several quarters.
Near-term Working Capital Cash UsageAccelerated working capital to support program ramps can temporarily drain liquidity and pressure reported free cash flow. Extended cash cycle days elevate funding needs and may force higher borrowing or slower buybacks, making near-term execution and gross-to-net cash conversion key monitoring points.
Supply Chain Tightening And Component RiskPersistent component lead-time and allocation risks can delay ramps, increase procurement cost, and compress margins for complex, low-volume products. Over several quarters, supply constraints may stagger revenue recognition across programs and raise working capital as the firm secures scarce parts ahead of demand.
Plexus News
PX4 FAQ
What was Plexus’s price range in the past 12 months?
Plexus lowest stock price was €100.00 and its highest was €262.00 in the past 12 months.
What is Plexus’s market cap?
Plexus’s market cap is €6.27B.
When is Plexus’s upcoming earnings report date?
Plexus’s upcoming earnings report date is Jul 29, 2026 which is in 15 days.
How were Plexus’s earnings last quarter?
Plexus released its earnings results on Apr 29, 2026. The company reported €1.799 earnings per share for the quarter, beating the consensus estimate of €1.652 by €0.147.
Is Plexus overvalued?
According to Wall Street analysts Plexus’s price is currently Undervalued.
Does Plexus pay dividends?
Plexus does not currently pay dividends.
What is Plexus’s EPS estimate?
Plexus’s EPS estimate is 1.87.
How many shares outstanding does Plexus have?
Plexus has 26,756,420 shares outstanding.
What happened to Plexus’s price movement after its last earnings report?
Plexus reported an EPS of €1.799 in its last earnings report, beating expectations of €1.652. Following the earnings report the stock price went up 0.952%.
Which hedge fund is a major shareholder of Plexus?
Currently, no hedge funds are holding shares in DE:PX4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Plexus Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€263.03 (39.91% Upside)
€263.03 (39.91% Upside)
Blogger Sentiment
Neutral
DE:PX4 Sentiment 50%
Sector Average 65%
Sector Average 65%
Insider Transactions
Sold Shares
Worth €4.1M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
96.43%
12-Months-Change
Fundamentals
Return on Equity
12.83%
Trailing 12-Months
Asset Growth
8.92%
Trailing 12-Months
Company Description
Plexus
Operating globally across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions, Plexus Corp. and its subsidiaries specialize in delivering advanced electronic manufacturing solutions. The company provides a comprehensive range of services, including design and development, efficient supply chain management, support for new product introductions, and core manufacturing capabilities, alongside essential aftermarket services. These offerings are tailored for businesses in key market segments such as healthcare/life sciences, industrial/commercial, aerospace/defense, and communications. Established in 1979, Plexus Corp. maintains its corporate headquarters in Neenah, Wisconsin.
PX4 Stock 12 Month Forecast
Average Price Target
€263.03
▲(39.91% Upside)
Technical Analysis
Options Prices
Currently, No data available
---